Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
Island Pharmaceuticals discuss the Dengue Fever pandemic
Dengue fever is a massive pandemic that continues to spread beyond geographical limits, with 400 million people affected each year. Island Pharmaceuticals (ASX: ILA) is at the forefront of the battle. Here, CEO David Foster talks about the issue:
